Fagron Sterile Services US Groundbreaking Lab Expansion

Fagron Sterile Services US Launches Cutting-Edge Laboratory Expansion at Wichita, KS 503B Outsourcing Campus

WICHITA, KS - MARCH 27, 2024 - Fagron Sterile Services US (FSS), a leading 503B outsourcing partner to patient-focused healthcare facilities, proudly announced plans for a new state-of-the-art quality control testing laboratory, at a groundbreaking ceremony held on their Wichita, KS manufacturing campus. The project will take approximately six months to complete, bolstering Fagron’s in-house testing capabilities, and bringing dozens of new R&D, chemistry, and microbiology jobs to the city– supporting Wichita’s continued expansion of STEM opportunities (science, technology, engineering, and math).

The advanced laboratory aligns Fagron’s quality-centered focus, partnering with hospitals, clinics, ambulatory surgery centers, and physician offices to support safe and effective patient care with ready-to-administer sterile medications for critical care, labor and delivery, ophthalmics, pain management, oncology, and more.

Wichita Mayor Lily Wu speaks with Fagron staff about their community and healthcare impact.

"As we break ground on our new cutting-edge quality control testing lab, Fagron is energized by the partnership we’ve found in Wichita – including the collaboration we’ve experienced with the city and state,” said Andrew Pulido, President, Fagron North America. “Fagron continues to support the healthcare supply chain, from raw materials and equipment for pharmacists through the delivery of high-quality, ready-to-administer sterile medications from FSS – we're advancing patient safety in communities nationwide, including Wichita.”

“Our amazing team has made FSS one of the best places to work in Wichita, according to a recent poll,” said Jason McGuire, SVP of Operations, FSS. "As we embark on the construction of our advanced quality testing capabilities, we are not just building a lab; we are expanding capacity for innovation and opportunities for Wichita.”

“As the only globally integrated 503b, FSS plays a critical role in supporting a consistent supply of essential medicines to healthcare providers across the US — a heightened responsibility amid the prevailing drug shortage crisis,” emphasized Ray Dixon, SVP of Commercial Operations at FSS. "This expansion underscores our dedication to elevating patient care."

With operations across more than 30 countries, Fagron’s legacy as a global leader in personalized medicine spans over three decades. FSS, which began as a small operation on Wichita’s west side, has grown to become a leader in 503B Outsourcing, now operating three large facilities out of Wichita, KS and Boston, MA, and a corporate office in Austin, TX.

Mayor Lily Wu expressed enthusiasm for the groundbreaking, highlighting its significance for the city's future.

"This groundbreaking event symbolizes continued progress for STEM investments in Wichita. The new laboratory not only introduces cutting-edge technology and capabilities but will also strengthen the city's workforce by bringing in skilled STEM professionals," said Mayor Wu. "Fagron's quality testing lab expansion demonstrates their dedication to enhancing healthcare outcomes and aligns perfectly with our city's values of trust and service."

The pharmaceutical outsourcing services FSS provides also combat ongoing healthcare staffing deficiencies. FSS is registered and inspected by the FDA, DEA and boards of pharmacy across all 50 states, operating in compliance with cGMP manufacturing standards.

The groundbreaking ceremony included FSS staff, Fagron management, community leaders, and construction partners and took place outside the future laboratory site.


Listen: Wichita Mayor Lily Wu Speaks at Groundbreaking Event

About Fagron Sterile Services

As a subsidiary of Fagron, a leading global company active in pharmaceutical compounding, focusing on delivering personalized medicine to hospitals, pharmacies, clinics and patients in more than 30 countries, Fagron Sterile Services US (FSS) is the only globally integrated 503B creating supply chain resiliency while advancing patient safety. FSS is a trusted 503B outsourcing partner to thousands of hospitals, ambulatory surgery centers, and other healthcare facilities in the US.

With an unwavering commitment to quality, safety, and innovation, FSS’ FDA-registered and inspected cGMP compliant operations support demand out of three facilities across Wichita, KS and Boston, MA, plus a corporate office in Austin, TX. FSS plays a pivotal role in addressing the US drug shortage crisis and supporting the availability of high-quality sterile medications in all 50 states.

FSS’ portfolio includes support for Critical Care, Labor and Delivery, Ophthalmics, Pain Management, and Oncology, while offering other innovative specialty solutions like the only sterile LET Gel available in the marketplace, and a revolutionary Avastin presentation. Through its dedication to providing a reliable supply of essential medications, Fagron Sterile Services US helps empower patient care, contributing to the overall well-being of communities nationwide.


Visit fagronsterile.com to download a product catalog, schedule a free consultation, and learn more today.

Sean Jones, MBA
Senior Director of Marketing at Fagron North America, with more than a decade of experience in the pharmaceutical and healthcare industries.